Economic and societal burden of myasthenia gravis in Denmark, Finland, and Sweden: A population‐based registry study
This population-based study shows a high level of HCRU and a significant direct and indirect economic burden of MG across three Nordic countries, especially for severe forms of MG.
Authors
- John Vissing (ORCID: https://orcid.org/0000-0001-6144-8544)
- Tero Ylisaukko‐oja
- Sari Atula (ORCID: https://orcid.org/0000-0003-1293-9325)
- Ingrid Lindberg (ORCID: https://orcid.org/0000-0002-6549-6065)
- Aino Vesikansa (ORCID: https://orcid.org/0000-0002-6386-9956)
- Fredrik Berggren (ORCID: https://orcid.org/0000-0002-2267-0086)
- Fredrik Piehl (ORCID: https://orcid.org/0000-0001-8329-5219)
- Juha Mehtälä (ORCID: https://orcid.org/0000-0003-4088-8561)
- Didier Pitsi
- Evangelos Tsitlakidis
- Riina‐Minna Väänänen
Institutions
- University of Copenhagen (DK)
- Karolinska University Hospital (SE)
- University of Helsinki (FI)
- Helsinki University Hospital (FI)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- Karolinska Institutet (SE)
- Hellenic Agency for Local Development and Local Government (GR)
- UCB Pharma (Belgium) (BE)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2024-10-09
- DOI
- https://doi.org/10.1111/ene.16511
- Citations
- 7
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 2.58
Funders
- Biogen
- UCB Pharma